Leaflet ANAFRANIL 25mg sugar-coated tablets

Indicated for: depression; obsessive-compulsive disorder

Route of administration: oral

Substance: clomipramine (antidepressant)

ATC: N06AA04 (Nervous system | Antidepressants | Non-selective monoamine reuptake inhibitors)

Precautions:
Driving impairment
Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Seizure risk
Seizure risk

This medicine may increase the risk of seizures.

Suicidal ideation / mental changes
Suicidal ideation / mental changes

Seek medical help if suicidal thoughts or major behavior changes occur.

Withdrawal / do not stop abruptly
Withdrawal / do not stop abruptly

Do not stop treatment abruptly without medical advice.

Drowsiness / sedation
Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Clomipramine is a tricyclic antidepressant (TCA) primarily used to treat obsessive-compulsive disorder (OCD). It is also indicated for the treatment of major depression, panic attacks, phobias, anxiety disorders, and, in some cases, chronic pain or nocturnal enuresis in children.

Clomipramine works by increasing the levels of serotonin and norepinephrine in the brain by inhibiting their reuptake. This mechanism helps regulate mood and reduce symptoms of anxiety and obsessions. Therapeutic effects may take 2-4 weeks to become noticeable.

While effective, clomipramine can cause side effects. The most common include dry mouth, constipation, drowsiness, dizziness, weight gain, and excessive sweating. In rare cases, it may cause more serious effects, such as cardiac arrhythmias, seizures, or manic symptoms. Patients should be monitored for signs of worsening depression or suicidal thoughts, especially at the beginning of treatment.

Clomipramine should be used as directed by a doctor, and the dosage should be gradually adjusted to minimize the risk of side effects. Alcohol consumption is contraindicated during treatment, as it may enhance sedative effects. Concurrent use with monoamine oxidase inhibitors (MAOIs) should also be avoided due to the risk of severe reactions. If severe side effects or unusual symptoms occur, immediate medical attention is necessary.

ANAFRANIL 25mg sugar-coated tablets NOVARTIS, clomipramine

General data about ANAFRANIL 25mg

  • Substance: clomipramine
  • Date of latest medicines list: 01-06-2026
  • Product code: W01359001
  • Concentration: 25mg
  • Pharmaceutical form: sugar-coated tablets
  • Quantity: 30
  • Product type: Original
  • Price: 16.47 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: NOVARTIS PHARMA GMBH - GERMANIA
  • Holder: NOVARTIS PHARMA GMBH - GERMANIA
  • Number: 11744/2019/01
  • Shelf life: 5 years

Concentrations available for clomipramine

  • 10mg
  • 25mg

Compensation lists for ANAFRANIL 25mg Novartis

A - Sublist A with 90% discount from the reference price

Price

Copayment

Patient

16.47 RON

14.82 RON

1.65 RON